EDCTP-CEPI Lassa Fever Vaccines Call – Online information meeting
The Joint EDCTP-CEPI Lassa Fever Vaccines Call with a budget of €40 million aims to support distinct strategic actions (clinical research activities) which are part of efforts to prepare and conduct a large-scale clinical trial that has the potential to achieve proof of concept and/or the demonstration of pivotal efficacy of novel candidate vaccines against LASV.
As EDCTP and CEPI streamline their processes and procedures in selecting, funding and monitoring the future large-scale Lassa vaccine trials, it is important for those preparing proposals to have a good understanding of the requirements set by both funders.
27 Jan 2020 at 2:00 PM (Amsterdam time), EDCTP and CEPI will hold an Online Information Meeting for potential applicants to this Joint EDCTP-CEPI Lassa Fever Vaccines Call.
The Meeting will include:
- Presentations by EDCTP and CEPI, covering the following:
- Application process;
- Evaluation procedures;
- Grant preparation process; and
- Project monitoring and reporting
- Q&A session based on questions sent prior to/or raised during the meeting.
After the meeting, an audio record will be available for later access and/or sharing.
To access the Meeting, registration is required and can be done via this link:
https://zoom.us/meeting/register/v5IsdOiuqTsvY6Xiu1_HNxd0d4tUXrtC_w
For specific questions related to this call for proposals, or further clarification on this upcoming Online Information Meeting, please contact Jean Marie Vianney Habarugira (habarugira@edctp.org)